HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer

Prostate cancer (CaP) is the most common cancer among adult men in the Western world. Better insight into its tumor-activating pathways may facilitate the development of targeted therapies. In this study, we show that patients who develop prostate tumors with low levels of PTEN and high levels of HE...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ahmad, Imran, Patel, Rachana, Singh, Lukram Babloo, Nixon, Colin, Seywright, Morag, Barnetson, Robert J., Brunton, Valerie G., Muller, William J., Edwards, Joanne, Sansom, Owen J., Leung, Hing Y.
Formato: Artigo
Lenguaje:Inglês
Publicado: National Academy of Sciences 2011
Materias:
Biological Sciences
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3182686/
https://ncbi.nlm.nih.gov/pubmed/21930937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1101263108
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares